ExodusPoint Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,865
| Closed | -$92K | – | 1344 |
|
|
2025
Q1 | $92K | Buy |
59,865
+49,228
| +463% | +$75.7K | ﹤0.01% | 1289 |
|
|
2024
Q4 | $26K | Buy |
+10,637
| New | +$26K | ﹤0.01% | 1308 |
|
|
2023
Q4 | – | Sell |
-146,454
| Closed | -$1M | – | 1334 |
|
|
2023
Q3 | $1M | Buy |
+146,454
| New | +$1M | 0.01% | 930 |
|
|
2023
Q1 | – | Sell |
-14,753
| Closed | -$232K | – | 1607 |
|
|
2022
Q4 | $232K | Buy |
+14,753
| New | +$232K | ﹤0.01% | 1368 |
|
|
2021
Q3 | – | Sell |
-28,975
| Closed | -$509K | – | 1981 |
|
|
2021
Q2 | $509K | Sell |
28,975
-111,880
| -79% | -$1.97M | 0.01% | 1313 |
|
|
2021
Q1 | $3.55M | Sell |
140,855
-81,793
| -37% | -$2.06M | 0.05% | 350 |
|
|
2020
Q4 | $1.44M | Buy |
+222,648
| New | +$1.44M | 0.01% | 636 |
|